Seeking Alpha

Goldman Sachs weighs in on the pharmacy wars, noting CVS Caremark (CVS +2.2%) still has room to...

Goldman Sachs weighs in on the pharmacy wars, noting CVS Caremark (CVS +2.2%) still has room to grow based on its "distinctive positioning" in the sector. Despite all the sound and fury from Walgreen (WAG -0.1%) on recapturing its lost customers back, the opposite appears to be the reality as the CVS share in the prescription market rises instead of falls.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|